ARNALDO V ORELLANA MOLINA

Allopathic & Osteopathic Physicians|General Practice TAMPA, FL NPI 1477844652

General Payments — all program years on this page

$5,068.10

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 129
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $643.03 across 20 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $643.0320

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $353.8413
2019 $915.8528
2020 $693.2012
2021 $1,043.1913
2022 $761.3319
2023 $657.6624
2024 $643.0320

Records — PY2024 (20)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1086187462 Bayer Healthcare Pharmaceuticals Inc. $26.83 02/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096948807 Novo Nordisk Inc $20.10 09/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097307064 Novo Nordisk Inc $21.84 03/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104321998 AstraZeneca Pharmaceuticals LP $19.71 02/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104547218 AstraZeneca Pharmaceuticals LP $18.74 02/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105321953 AstraZeneca Pharmaceuticals LP $14.09 01/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105657552 AstraZeneca Pharmaceuticals LP $15.77 04/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105687251 AstraZeneca Pharmaceuticals LP $84.14 03/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105703656 AstraZeneca Pharmaceuticals LP $14.32 05/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105728189 AstraZeneca Pharmaceuticals LP $16.76 05/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105900834 AstraZeneca Pharmaceuticals LP $13.05 03/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118026735 Boehringer Ingelheim Pharmaceuticals, Inc. $19.06 02/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118026737 Boehringer Ingelheim Pharmaceuticals, Inc. $20.17 03/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118954516 Otsuka America Pharmaceutical, Inc. $21.92 02/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118954518 Otsuka America Pharmaceutical, Inc. $21.45 03/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118954520 Otsuka America Pharmaceutical, Inc. $121.82 03/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1127776665 EVOKE PHARMA, INC. $117.92 05/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131585848 PFIZER INC. $14.32 03/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136051947 Lilly USA, LLC $21.24 05/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136064024 Lilly USA, LLC $19.78 02/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.